Magnesium Acetate Crystallisation: Tetrahydrate Purity
For pharmaceutical manufacturers, magnesium acetate tetrahydrate is an API where formulation failure is decided at the crystallisation stage — not during finished product development. Cooling rate, vacuum concentration, and drying temperature determine whether four water molecules of crystallisation are preserved intact or lost to an anhydrous form that behaves differently across every downstream application. Most B2B sourcing decisions are made on assay percentage alone, without verifying tetrahydrate hydration state through thermogravimetric analysis. For formulators working across pharmaceutical buffering, IV preparations, and biotechnology reagents, this is a formulation risk.
In this blog, we examine the magnesium acetate crystallisation process, purity specifications, and what B2B buyers must verify before sourcing.
Key Takeaways:
- Magnesium acetate tetrahydrate purity is set at 98.0–102.0% BP/USP; ACS grade requires a tighter 99.5-102.0% assay range.
- Controlled cooling rate during crystallisation directly determines whether pharmaceutical-grade impurity thresholds are achievable at scale.
- Tetrahydrate integrity must be verified separately via thermogravimetric analysis; standard assay testing does not confirm hydration state.
Quick Answer: Magnesium acetate crystallisation produces tetrahydrate crystals through controlled cooling of a concentrated magnesium acetate solution, with purity determined by cooling rate, centrifugation, and controlled drying that preserves four water molecules of crystallisation.
What Is Magnesium Acetate Tetrahydrate
Magnesium acetate tetrahydrate is the magnesium salt of acetic acid in its most stable hydrated form, identified as Mg(CH₃COO)₂·4H₂O under CAS 16674-78-5, molecular weight 214.46. The tetrahydrate designation indicates four water molecules of crystallisation integrated directly into the crystal lattice. This structural feature distinguishes it from anhydrous magnesium acetate in solubility, stability, and handling behaviour. The compound is a colourless monoclinic crystal with a density of 1.454 g/cm³, a melting point of 80°C, and a high water solubility of 120g/100mL at 15°C.
Its pH range of 7.2-8.7 at 25°C makes it compatible with pharmaceutical buffering applications that require neutral to mildly alkaline conditions. For B2B buyers, the tetrahydrate form’s physical profile determines whether a supplier’s crystallisation process preserves the hydration state the application demands.
The Magnesium Acetate Crystallisation Process
Magnesium acetate crystallisation is a multi-stage controlled process where each parameter- reaction chemistry, concentration, cooling rate, and drying conditions- directly determines whether the final tetrahydrate form meets pharmaceutical-grade purity specifications.
Raw Material Selection
High-purity magnesium oxide or magnesium carbonate is selected as the starting material, reacted with glacial acetic acid under controlled aqueous conditions. Using magnesium carbonate releases CO₂ as a by-product, requiring controlled reaction-vessel conditions throughout.
Vacuum Concentration
Following the neutralisation reaction, the magnesium acetate solution is concentrated under vacuum to achieve target purity and composition before crystallisation begins with a step that directly determines the impurity profile of the final tetrahydrate crystal.
Controlled Cooling Crystallisation
The concentrated solution is cooled gradually under controlled temperature conditions, allowing magnesium acetate tetrahydrate crystals to form. Cooling rate is a critical variable; uncontrolled cooling produces low-purity crystals that trap soluble impurities within the crystal lattice structure.
Centrifugation and Separation
Formed tetrahydrate crystals are separated from the remaining mother liquor via centrifugation. The mother liquor contains residual impurities, unreacted components, and dissolved salts; complete separation at this stage is essential to meet pharmaceutical-grade impurity limits downstream.
Controlled Drying
The separated crystals are dried under controlled temperature conditions specifically designed to remove surface moisture while preserving the four water molecules of crystallisation. Overdrying converts tetrahydrate to anhydrous magnesium acetate — a critical quality failure that changes the product’s molecular weight, solubility, and application performance entirely.
Tetrahydrate Purity and Quality Control Specifications
Magnesium acetate crystallisation quality is measured against pharmacopoeial impurity thresholds, and magnesium acetate tetrahydrate specifications are more demanding than general magnesium acetate quality control standards.
- Pharmaceutical-grade magnesium acetate tetrahydrate must meet a 98.0-102.0% assay range, with water of crystallisation included in the calculation [1].
- Magnesium acetate quality control sets heavy metals at 5 ppm maximum, with lead and iron at 5 ppm, non-negotiable for pharmaceutical and biotechnology applications.
- Magnesium acetate crystals must meet chloride ≤0.001%, sulfate ≤0.005%, calcium ≤0.01%, and insoluble matter ≤0.005%, determined entirely by the crystallisation process.
- Magnesium acetate tetrahydrate is available in ACS Reagent, BP/Ph Eur, USP, and IP grades, each with distinct purity requirements that must be specified before sourcing.
- Confirm water of crystallisation via thermogravimetric analysis or loss on drying; standard magnesium acetate assay testing does not automatically verify the tetrahydrate hydration state.
Applications of Magnesium Acetate Tetrahydrate
Magnesium acetate tetrahydrate is used across pharmaceutical, biotechnology, textile, industrial, and analytical categories, making grade selection at the sourcing stage the primary formulation decision.
- Acts as a buffering agent and pH stabiliser in drug formulations, injectable preparations, and dialysis solutions where ionic consistency is critical.
- Supplies magnesium ions as enzyme cofactors and acetate ions for pH-stable buffer systems in DNA extraction, molecular biology, and biochemical research protocols.
Used in tablets, capsules, and IV fluids as a directly bioavailable magnesium source for pharmaceutical and nutraceutical finished product formulations.
Functions as a mordant in dyeing processes, improving dye adhesion to natural fibres, the primary industrial application where pharmaceutical-grade crystallisation purity is not required.
Serves as a catalyst in plastics and textile chemical reactions, and as a reference standard in HPLC and ICP-MS laboratory quality control methods.
Sourcing Magnesium Acetate Tetrahydrate From WBCIL
For B2B buyers sourcing magnesium acetate tetrahydrate, the crystallisation process documentation is as important as the final purity certificate. Controlled cooling rate, tetrahydrate integrity verification, and batch-specific CoA with full impurity profiling are the minimum requirements before any formulation commitment. Pharmacopoeial grade specification, BP, USP, or IP, must be confirmed at the sourcing stage, not assumed from a product listing. WBCIL manufactures magnesium acetate tetrahydrate in WHO-GMP and cGMP-certified infrastructure, supplying pharmaceutical, nutraceutical, and industrial formulators across 30+ countries with batch-verified purity, customisable particle size, and full DMF documentation support, backed by 64 years of magnesium API manufacturing expertise.
Final Thoughts
Magnesium acetate crystallisation is a precision process where cooling rate, vacuum concentration, and drying temperature determine whether the tetrahydrate form reaches the buyer within pharmacopoeial specification. An assay result within 98.0–102.0% does not confirm tetrahydrate integrity unless water of crystallisation is independently verified through thermogravimetric analysis. For B2B buyers, the actionable steps are clear: specify pharmacopoeial grade before sourcing, request thermogravimetric data alongside the CoA, and confirm the supplier’s drying process is validated at batch scale. Never assume pharmaceutical-grade labelling includes tetrahydrate-specific verification. WBCIL’s WHO-GMP certified infrastructure and 64 years of magnesium API manufacturing experience provide the process documentation depth this crystallisation-sensitive product requires.
- Won S, Kang HY. Production of Magnesium Dilactate through Lactic Acid Fermentation with Magnesium Carbonate. Microorganisms. 2024 Oct 3;12(10):2011. doi: 10.3390/microorganisms12102011. PMID: 39458320; PMCID: PMC11509355.
It is the magnesium salt of acetic acid with four water molecules integrated into the crystal lattice (CAS 16674-78-5; molecular weight 214.46).
Cooling rate, vacuum concentration, and centrifugation determine impurity entrapment. Uncontrolled cooling produces crystals that fail pharmaceutical-grade chloride, sulfate, and heavy metal thresholds.
ACS requires 99.5-102.0% assay for analytical applications. BP/USP accepts 98.0-102.0% for pharmaceutical formulations; specify the grade before sourcing.
Thermogravimetric analysis or loss on drying confirms the four water molecules are preserved. Standard assay testing alone does not verify hydration state.
Batch-specific CoA, thermogravimetric data, pharmacopoeial grade certificate, WHO-GMP certification, and DMF documentation are minimum requirements before any formulation commitment.
